Dominick Tyer writes in the Digital Intelligence blog:
[buttonp]Merck and Ayogo working together on mobile app to improve adherence[/buttonp]
Merck & Co is working on a new mobile app for type 2 diabetes patients to help them keep taking their medicines as prescribed.
The pharma company is collaborating on the Type 2 Travelers Project with behavioural change gaming firm Ayogo and the game was showcased at the mHealth Summit held near Washington, DC earlier this month.
It involves uses picking an avatar and playing a series of games – the gold coins they can win help them travel around the world – all with the ultimate aim of improving patient adherence.
Still in the beta-testing stage, the Type 2 Travelers Project has been through two pilots with academic partners and a third is currently ongoing.